Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jefferson Becker

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|September 8, 2004
Impaired P50 sensory gating in Machado-Joseph diseaseEduardo S Ghisolfi, Gustavo H B Maegawa, Jefferson Becker, et al.
Arquivos De Neuro-Psiquiatria|July 15, 2011
Pattern of P50 suppression deficit in patients with epilepsy and individuals with schizophreniaJefferson Becker, Irenio Gomes da Silva Filho, Hélio Fernandes da Silva Filho, et al.
CNS Drugs|July 18, 2018
Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: A Network Meta-AnalysisRosa C Lucchetta, Fernanda S Tonin, Helena H L Borba, et al.
Multiple Sclerosis and Related Disorders|February 8, 2018
Correlation between the corpus callosum index and brain atrophy, lesion load, and cognitive dysfunction in multiple sclerosisLucas Immich Gonçalves, Giordani Rodrigues Dos Passos, Lucas Piccoli Conzatti, et al.
BMC Health Services Research|March 25, 2016
Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter studyNilceia Lopes da Silva, Maira L S Takemoto, Alfredo Damasceno, et al.
Journal of Neuroimmunology|November 14, 2020
Correlation between IL-31 and sCD40L plasma levels in Fingolimod-treated patients with Relapsing-Remitting Multiple Sclerosis (RRMS)Marcus Vinícius Magno Gonçalves, Wesley Nogueira Brandão, Carla Longo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 18, 2022
Interleukin-31 and soluble CD40L: new candidate serum biomarkers that predict therapeutic response in multiple sclerosisIsabelle Pastor Bandeira, André Eduardo de Almeida Franzoi, Giulia Murillo Wollmann, et al.
Journal of the Neurological Sciences|September 11, 2021
Multiple sclerosis care units in Latin America: Consensus recommendations about its objectives and functioning implementationEdgardo Cristiano, Patricio Abad, Jefferson Becker, et al.
Frontiers in Neurology|June 19, 2026
Global overview of multiple sclerosis care units: an international cross-sectional surveyPer Soelberg Sörensen, Paola F Zaratin, Mario Alberto Battaglia, et al.
Multiple Sclerosis and Related Disorders|October 21, 2023
Neurological syndromes and potential triggers associated with antibodies to neuronal surface antigensBruna Klein da Costa, Paula de Oliveira Pinto, Lia Staub, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|September 8, 2004
Impaired P50 sensory gating in Machado-Joseph diseaseEduardo S Ghisolfi, Gustavo H B Maegawa, Jefferson Becker, et al.
Arquivos De Neuro-Psiquiatria|July 15, 2011
Pattern of P50 suppression deficit in patients with epilepsy and individuals with schizophreniaJefferson Becker, Irenio Gomes da Silva Filho, Hélio Fernandes da Silva Filho, et al.
CNS Drugs|July 18, 2018
Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: A Network Meta-AnalysisRosa C Lucchetta, Fernanda S Tonin, Helena H L Borba, et al.
Multiple Sclerosis and Related Disorders|February 8, 2018
Correlation between the corpus callosum index and brain atrophy, lesion load, and cognitive dysfunction in multiple sclerosisLucas Immich Gonçalves, Giordani Rodrigues Dos Passos, Lucas Piccoli Conzatti, et al.
BMC Health Services Research|March 25, 2016
Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter studyNilceia Lopes da Silva, Maira L S Takemoto, Alfredo Damasceno, et al.
Journal of Neuroimmunology|November 14, 2020
Correlation between IL-31 and sCD40L plasma levels in Fingolimod-treated patients with Relapsing-Remitting Multiple Sclerosis (RRMS)Marcus Vinícius Magno Gonçalves, Wesley Nogueira Brandão, Carla Longo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 18, 2022
Interleukin-31 and soluble CD40L: new candidate serum biomarkers that predict therapeutic response in multiple sclerosisIsabelle Pastor Bandeira, André Eduardo de Almeida Franzoi, Giulia Murillo Wollmann, et al.
Journal of the Neurological Sciences|September 11, 2021
Multiple sclerosis care units in Latin America: Consensus recommendations about its objectives and functioning implementationEdgardo Cristiano, Patricio Abad, Jefferson Becker, et al.
Frontiers in Neurology|June 19, 2026
Global overview of multiple sclerosis care units: an international cross-sectional surveyPer Soelberg Sörensen, Paola F Zaratin, Mario Alberto Battaglia, et al.
Multiple Sclerosis and Related Disorders|October 21, 2023
Neurological syndromes and potential triggers associated with antibodies to neuronal surface antigensBruna Klein da Costa, Paula de Oliveira Pinto, Lia Staub, et al.
Pageof 8